Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2024-06-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于子公司收到药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (703 characters) from a company about its subsidiary receiving a drug registration certificate from the national drug regulatory authority. It contains no financial data, no detailed report, and no mention of financial results or management discussion. It is an official announcement about a regulatory approval event, not a financial report or management update. The document is not a report itself but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-13 Chinese
关于子公司收到化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (594 characters) regarding a subsidiary receiving approval for a chemical raw material drug listing from a regulatory authority (国家药品监督管理局 - National Medical Products Administration). It contains no financial data, no detailed report, and no mention of financial results or management changes. It is an official notification about a regulatory approval event. The document is not a report itself but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-12 Chinese
关于子公司收到药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about its subsidiaries receiving drug registration certificates from the national drug regulatory authority. It contains no financial statements, no management discussion of financial results, no earnings data, and no detailed report content. The document is short (1006 characters) and serves as an official notification of a regulatory approval event. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a voting result, board change, or financing update. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material event related to the company but does not fit other specific categories.
2024-05-28 Chinese
2023年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2023 annual dividend distribution plan approved at the 2023 Annual General Meeting held on May 24, 2024. It details the dividend amount per share, the record date, the ex-dividend date, and the method of dividend payment. The document does not contain financial statements or detailed financial performance data but rather communicates the dividend distribution specifics to shareholders. The document length is short (1889 characters) and it serves as a formal notice of dividend amount and payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-05-27 Chinese
东方华银关于福安药业2023年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of the company 福安药业（集团）股份有限公司. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the results of the votes on various agenda items including the 2023 annual report, audit report, financial statements, profit distribution, and amendments to the company bylaws. The document is not the actual annual report or audit report but a legal opinion on the AGM process and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the AGM. The document length (8325 characters) and content confirm it is not a brief announcement but a detailed legal opinion on the AGM and voting results. Therefore, the correct classification is DVA with high confidence.
2024-05-24 Chinese
2023年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of 福安药业（集团）股份有限公司. It includes information about the meeting date, attendance, voting results on various proposals including the 2023 annual reports, audit reports, profit distribution, appointment of auditors, amendments to the company charter, and future shareholder return plans. The document also contains legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official voting results and decisions made at the AGM rather than the full reports themselves. The document length is about 5331 characters, which is sufficient for a detailed voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-24 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.